CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Globe-Shaped, High-Density, Multi-Electrode Mapping Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05373862
NCT05373862N/ACompleted
CompareCT.gov

Clinical Evaluation of Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter

Biosense Webster, Inc.·interventional·Posted May 13, 2022·Updated Mar 3, 2025

In Brief

A clinical study evaluating Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter for Scar-related Atrial Tachycardia and 4 related conditions. Completed, enrolled 40 participants across 4 sites in 3 countries.

Detailed Summary

The purpose of this study is to assess the performance and safety for the use of the investigational catheter for intracardiac mapping in the atria and ventricles.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsScar-related Atrial Tachycardia, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Ventricular Tachycardia, Premature Ventricular Complex
CountriesBelgium, Croatia, Italy
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 13, 2022
Enrollment StartJul 29, 2022
Primary CompletionFeb 20, 2023
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 4.1 years ago

Interventions

Globe-Shaped, High-Density, Multi-Electrode Mapping Catheterdevice

Participants scheduled to have a clinically-indicated catheter mapping and ablation procedure using globe-shaped, high-density, multi-electrode mapping catheter for management of atrial procedure (scar-related atrial tachycardia, persistent atrial fibrillation, paroxysmal atrial fibrillation) and Ventricular procedures (ventricular tachycardia, premature ventricular complex).